Chang - Liu

Dr. Chang - Liu

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 September 2023 in Heliyon
Verified
Journal Article
Open access
DLDan Liang
Dan Liang
CLChang - Liu
Chang - Liu
MYMei - Yang
Mei - Yang
Acute lung injury (ALI)/acute respiratory distress syndrome (ARDS) is a serious clinical syndrome with a high morbidity and mortality. Presently, therapeutic approaches for ALI/ARDS primarily revolve around symptomatic supportive care encompassing mechanical ventilation and fluid management. Regrettably, the prognosis for most ALI/ARDS patients remains bleak due to the absence of effective treatment strategies. Even survivors of ALI/ARDS may have long-term pulmonary dysfunction and cognitive impairment. The quality of life has been seriously compromised. The emergence of mesenchymal stem cells (MSCs) and their exosomes has opened up an expansive realm of potential and optimism for addressing the plight of ALI/ARDS patients, as MSCs and their derived exosomes exhibit multifaceted capabilities, including anti-inflammatory properties, facilitation of tissue repair and regeneration, and apoptosis inhibition. Therefore, future research should focus on the possible mechanisms of MSCs and their derived exosomes for the treatment of ALI/ARDS and open up new avenues for their clinical applications.

1 October 2021 in Immunity
Verified
Journal Article
Closed access
SLShan-Shan Liu
Shan-Shan Liu
CLChang - Liu
Chang - Liu
XLXiao-Xi Lv
Xiao-Xi Lv
BCBing Cui
Bing Cui
JYJun Yan
Jun Yan
ZHZhuowei Hu
Zhuowei Hu

18 April 2025 in Scientific Reports
Verified
Journal Article
Open access
PDF file
DLDan Liang
Dan Liang
CLChang - Liu
Chang - Liu
XZXingyu Zhang
Xingyu Zhang
The relationship of dietary selenium intake and CVD remains unestablished. Our study aimed to investigate the relationship between dietary selenium intake and the risk of CVD in American adults. This cross-sectional study used data of 39,372 participants from the NHANES 2003–2018. We employed multivariable logistic regression and restricted cubic splines (RCS) to explore the association between dietary selenium intake and CVD risk. Subgroup analysis and interaction tests were also conducted to assess the influence of various covariates. For 39,372 individuals recruited in this study. The overall prevalence of CVD was 8.57%, and this prevalence decreased with increasing dietary selenium intake across tertiles. In the fully adjusted models, Tertile 2 of dietary selenium intake showed a 16% reduced risk of CVD. Subgroup analysis revealed that the association between dietary selenium intake and CVD risk remained consistent across different status. However, notably, the negative association between dietary selenium intake and the risk of ASCVD was significantly influenced by hypertension status. Dietary selenium intake could reduce the risk of CVD. A nonlinear association of dietary selenium intake with CVD risk was also revealed. These findings have important implications for establishing recommended dietary selenium intake levels to benefit public cardiovascular health.

18 August 2021 in Frontiers in Medicine
Verified
Journal Article
Open access
YSYue Sun
Yue Sun
QZQing Zhang
Qing Zhang
QZQin Zhang
Qin Zhang
CLChang - Liu
Chang - Liu
HZHong Zhang
Hong Zhang
GHGang Hou
Gang Hou
Background: The Xpert Mycobacterium tuberculosis/rifampin (MTB/RIF) assay has shown good diagnostic efficacy in brushing and biopsy tissue samples from patients with tracheobronchial tuberculosis (TBTB). However, its diagnostic value in bronchoalveolar lavage fluid (BALF) is still unclear. Therefore, the present retrospective study aimed to evaluate the diagnostic value of the Xpert MTB/RIF assay in BALF.Methods: The clinical data of 266 patients with suspected TBTB from January 2018 to October 2020 were pooled with complete details of bronchial brush and bronchoalveolar lavage samples. Smears of the bronchial brushings were stained with Auramine O stain to detect acid-fast bacilli (AFB), and BALF samples were used for culturing MTB with the BACTEC MGIT 960 system and the Xpert MTB/RIF assay. The diagnostic performance of these methods was assessed and compared.Results: A total of 266 patients suspected to have TBTB were enrolled in the final analysis. Of these patients, 179 patients were confirmed to have TBTB and 87 patients were non-TBTB. The sensitivity of the Xpert MTB/RIF assay in BALF (87.2%) was significantly higher than that of the brush smear for AFB (35.2%, p < 0.001). No significant difference was observed between the sensitivities of the Xpert MTB/RIF assay in BALF and MTB culture in BALF (87.2 vs. 84.9%, p = 0.542). The specificities of the Xpert MTB/RIF assay in BALF, MTB culture in BALF, and the bronchial brush smear were 97.7, 97.7, and 98.9%, respectively. The positive predictive value (PPV) and negative predictive value (NPV) of the Xpert MTB/RIF assay in BALF, MTB culture in BALF, and the bronchial brush smear were 98.7 and 78.7%, 98.7 and 75.9%, and 98.4 and 42.6%, respectively. Among the MTB culture-positive patients with TBTB detected by the Xpert assay, 27.0% (20/74) were identified to be resistant to RIF.Conclusions: The Xpert MTB/RIF assay in BALF enables a rapid and accurate diagnosis of TBTB and identification of RIF resistance, which is crucial for timely and proper treatment. Moreover, in patients with TBTB, BALF could be used as an alternative to bronchial brushing and biopsy tissues for the Xpert MTB/RIF assay.

29 January 2025 in Scientific Reports
Verified
Journal Article
Open access
PDF file
CLChang - Liu
Chang - Liu
GXGuoan Xiang
Guoan Xiang
DLDan Liang
Dan Liang
XZXuanbo Zhao
Xuanbo Zhao
KXKun Xiao
Kun Xiao
Lixin XieLixin Xie
Lixin Xie
Oxidative balance score (OBS) is a composite measures that assess the balance between pro-oxidant and antioxidant factors in an individual’s diet and lifestyle, with higher scores indicating greater antioxidant exposure. Despite its potential significance, there is a limited body of research exploring the relationship between OBS and all-cause and cardiovascular disease (CVD) mortality specifically in younger patients with diabetes. We aimed to investigate the possible relationship between OBS and all-cause and CVD mortality in younger patients with diabetes. Data for this study were obtained from the 2003–2018 NHANES. This study enrolled 3501 participants. The endpoints were all-cause and CVD mortality, determined by the National Death Index (NDI). OBS, which consists of 16 dietary factors and 4 lifestyle factors, is categorized into pro-oxidants and antioxidants. The OBS was categorized into four quartiles (Q1-Q4). We used multivariable Cox proportional hazards regression models to examine the association between continuous and quartile measures of OBS, lifestyle OBS (lifestyle antioxidants such as physical activity, etc., and lifestyle pro-oxidants such as alcohol, smoking, etc.), and dietary OBS (dietary antioxidants such as fiber, β-carotene, riboflavin, etc., and dietary pro-oxidants, such as total fat, etc.) with all-cause and CVD mortality. Additionally, we explored restricted cubic spline (RCS) analysis and also performed subgroup analyses and interaction tests. The occurrence of 409 all-cause deaths (11.7%) and 108 CVD-related deaths (3.1%) was recorded during the follow-up period. Our results found that OBS, lifestyle OBS, and dietary OBS were negatively associated with patients’ all-cause and CVD mortality. The RCS analysis further validated the association of a linear negative correlation between OBS and all-cause and CVD mortality. The results of our subgroup analyses revealed that the negative association between OBS and CVD mortality may be influenced by alcohol use. In conclusion, results from a nationally representative study of younger American patients with diabetes suggest a negative association between OBS, lifestyle OBS, and dietary OBS and all-cause and CVD mortality. Antioxidant-rich diets and lifestyle improvements are essential for reducing all-cause and CVD mortality in patients.